NCT06136741Phase 2Active not recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

Study sponsor: Nektar Therapeutics · NKTR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-06Actual
Enrollment · participants396Estimated
Source updated2026-08-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview